Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
02 2021
Historique:
received: 06 07 2020
revised: 21 09 2020
accepted: 30 09 2020
pubmed: 14 10 2020
medline: 24 8 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

Thromboelastometry/elastography (ROTEM/TEG) showed promising results for diagnosis of sepsis-induced coagulopathy, but their association with the outcome is unclear. Our aim was to assess any difference in ROTEM/TEG measurements between septic survivors and non-survivors. Pubmed, Web of Science, Embase and Cochrane Library databases were investigated. The research aimed to include any randomized or observational study: i) on septic adult patients admitted to Intensive Care Unit (ICU) or Emergency Department (ED); ii) including ROTEM/TEG; iii) assessing mortality. Seven prospective and four retrospective observational studies (952 patients) were included. According to the INTEM/kaolin-assay, clotting time (CT)/R (standardized mean difference(SMD) -0.29, 95% CI -0.49 to -0.09, p = 0.004) and clot formation time (CFT)/K (SMD -0.42, 95% CI -0.78 to -0.06, p = 0.02) were shorter in survivors. According to the EXTEM-assay, CT was shorter (MD -11.66 s, 95% CI -22.59 to -0.73, p = 0.04), while MCF was higher (MD 3.49 mm, 95% CI 0.43 to 6.55, p = 0.03) in survivors. A hypocoagulable profile was more frequent in non-survivors (OR 0.31, 95%CI 0.18 to 0.55, p < 0.0001). Overall, the risk of bias of the included studies was moderate and the quality of evidence low. Hypocoagulability and lower MCF in EXTEM may be associated with higher mortality in sepsis.

Sections du résumé

BACKGROUND
Thromboelastometry/elastography (ROTEM/TEG) showed promising results for diagnosis of sepsis-induced coagulopathy, but their association with the outcome is unclear. Our aim was to assess any difference in ROTEM/TEG measurements between septic survivors and non-survivors.
METHODS
Pubmed, Web of Science, Embase and Cochrane Library databases were investigated. The research aimed to include any randomized or observational study: i) on septic adult patients admitted to Intensive Care Unit (ICU) or Emergency Department (ED); ii) including ROTEM/TEG; iii) assessing mortality.
RESULTS
Seven prospective and four retrospective observational studies (952 patients) were included. According to the INTEM/kaolin-assay, clotting time (CT)/R (standardized mean difference(SMD) -0.29, 95% CI -0.49 to -0.09, p = 0.004) and clot formation time (CFT)/K (SMD -0.42, 95% CI -0.78 to -0.06, p = 0.02) were shorter in survivors. According to the EXTEM-assay, CT was shorter (MD -11.66 s, 95% CI -22.59 to -0.73, p = 0.04), while MCF was higher (MD 3.49 mm, 95% CI 0.43 to 6.55, p = 0.03) in survivors. A hypocoagulable profile was more frequent in non-survivors (OR 0.31, 95%CI 0.18 to 0.55, p < 0.0001). Overall, the risk of bias of the included studies was moderate and the quality of evidence low.
CONCLUSIONS
Hypocoagulability and lower MCF in EXTEM may be associated with higher mortality in sepsis.

Identifiants

pubmed: 33049490
pii: S0883-9441(20)30713-9
doi: 10.1016/j.jcrc.2020.09.034
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-13

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Annalisa Boscolo (A)

Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy. Electronic address: annalisa.boscolo@gmail.com.

Luca Spiezia (L)

Department of Medicine, Thrombotic and Haemorrhagic Diseases Unit, University of Padua, Italy.

Alessandro De Cassai (A)

Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.

Laura Pasin (L)

Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.

Elisa Pesenti (E)

Department of Medicine-DIMED, University of Padua, Italy.

Matteo Zatta (M)

Department of Medicine-DIMED, University of Padua, Italy.

Stefano Zampirollo (S)

Department of Medicine-DIMED, University of Padua, Italy.

Giulio Andreatta (G)

Department of Medicine-DIMED, University of Padua, Italy.

Nicolò Sella (N)

Department of Medicine-DIMED, University of Padua, Italy.

Tommaso Pettenuzzo (T)

Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy.

Kirstin Rose (K)

Department of Obstetrics and Gynaecology, Royal Alexandria Hospital, Paisley, Scotland, United Kingdom.

Paolo Simioni (P)

Department of Medicine, Thrombotic and Haemorrhagic Diseases Unit, University of Padua, Italy.

Paolo Navalesi (P)

Anaesthesia and Intensive Care Unit, Padua University Hospital, Italy; Department of Medicine-DIMED, University of Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH